Distribution and predictive performance of the temporal phase of dynamic spot sign appearance in acute intracerebral hemorrhage.
Aged
Aged, 80 and over
Arteries
/ diagnostic imaging
Cerebral Angiography
/ methods
Cerebral Hemorrhage
/ complications
Cerebrum
/ blood supply
Computed Tomography Angiography
/ methods
Extravasation of Diagnostic and Therapeutic Materials
/ diagnosis
Female
Follow-Up Studies
Hematoma
/ diagnosis
Hospital Mortality
Humans
Male
Predictive Value of Tests
Prognosis
Prospective Studies
Sensitivity and Specificity
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
21
04
2020
accepted:
30
06
2020
entrez:
8
8
2020
pubmed:
8
8
2020
medline:
2
10
2020
Statut:
epublish
Résumé
Dynamic CT angiography (dCTA) contrast extravasation, known as the "dynamic spot sign", can predict hematoma expansion (HE) in intracerebral hemorrhage (ICH). Recent reports suggest the phase of spot sign appearance is related to the magnitude of HE. We used dCTA to explore the association between the phase of spot sign appearance and HE, clinical outcome, and contrast extravasation rates. We assessed consecutive patients who presented with primary ICH within 4.5 hours from symptom onset who underwent a standardized dCTA protocol and were spot sign positive. The independent variable was the phase of spot sign appearance. The primary outcome was significant HE (either 6 mL or 33% growth). Secondary outcomes included total absolute HE, mortality, and discharge mRS. Mann-Whitney U, Fisher's exact test, and logistic regression were used, as appropriate. Of the 35 patients with spot signs, 27/35 (77%) appeared in the arterial phase and 8/35 (23%) appeared in the venous phase. Thirty patients had follow-up CT scans. Significant HE was seen in 14/23 (60.87%) and 3/7 (42.86%) of arterial and venous cohorts, respectively (p = 0.67). The sensitivity and specificity in predicting significant HE were 82% and 31% for the arterial phase and 18% and 69% for the venous phase, respectively. There was a non-significant trend towards greater total HE, in-hospital mortality, and discharge mRS of 4-6 in the arterial spot sign cohort. Arterial spot signs demonstrated a higher median contrast extravasation rate (0.137 mL/min) compared to venous spot signs (0.109 mL/min). Our exploratory analyses suggest that spot sign appearance in the arterial phase may be more likely associated with HE and poorer prognosis in ICH. This may be related to higher extravasation rates of arterial phase spot signs. However, further studies with larger sample sizes are warranted to confirm the findings.
Sections du résumé
BACKGROUND
Dynamic CT angiography (dCTA) contrast extravasation, known as the "dynamic spot sign", can predict hematoma expansion (HE) in intracerebral hemorrhage (ICH). Recent reports suggest the phase of spot sign appearance is related to the magnitude of HE. We used dCTA to explore the association between the phase of spot sign appearance and HE, clinical outcome, and contrast extravasation rates.
METHODS
We assessed consecutive patients who presented with primary ICH within 4.5 hours from symptom onset who underwent a standardized dCTA protocol and were spot sign positive. The independent variable was the phase of spot sign appearance. The primary outcome was significant HE (either 6 mL or 33% growth). Secondary outcomes included total absolute HE, mortality, and discharge mRS. Mann-Whitney U, Fisher's exact test, and logistic regression were used, as appropriate.
RESULTS
Of the 35 patients with spot signs, 27/35 (77%) appeared in the arterial phase and 8/35 (23%) appeared in the venous phase. Thirty patients had follow-up CT scans. Significant HE was seen in 14/23 (60.87%) and 3/7 (42.86%) of arterial and venous cohorts, respectively (p = 0.67). The sensitivity and specificity in predicting significant HE were 82% and 31% for the arterial phase and 18% and 69% for the venous phase, respectively. There was a non-significant trend towards greater total HE, in-hospital mortality, and discharge mRS of 4-6 in the arterial spot sign cohort. Arterial spot signs demonstrated a higher median contrast extravasation rate (0.137 mL/min) compared to venous spot signs (0.109 mL/min).
CONCLUSION
Our exploratory analyses suggest that spot sign appearance in the arterial phase may be more likely associated with HE and poorer prognosis in ICH. This may be related to higher extravasation rates of arterial phase spot signs. However, further studies with larger sample sizes are warranted to confirm the findings.
Identifiants
pubmed: 32760077
doi: 10.1371/journal.pone.0236196
pii: PONE-D-20-11565
pmc: PMC7410294
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0236196Déclaration de conflit d'intérêts
Co-authors DD and MJH are authors of the Method and System for Identifying Bleeding patent (PAT 80049P-2 US). This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
AJNR Am J Neuroradiol. 2011 Nov-Dec;32(10):1879-84
pubmed: 21885714
Stroke. 2016 Mar;47(3):695-700
pubmed: 26846857
Stroke. 2014 Mar;45(3):734-9
pubmed: 24481974
PLoS One. 2014 Mar 03;9(3):e90431
pubmed: 24594897
Stroke. 2009 May;40(5):1672-6
pubmed: 19286577
Can J Neurol Sci. 2009 Jul;36(4):456-61
pubmed: 19650356
Stroke. 2015 Sep;46(9):2498-503
pubmed: 26243220
Neurology. 2011 Apr 5;76(14):1238-44
pubmed: 21346218